Facit | Cancer Breakthroughs Realized
Facit | Cancer Breakthroughs Realized
  • About
    • About FACIT
    • Our Network
    • Leadership
    • Careers
    • Contact
  • Portfolio
  • Funds
    • Funds Overview
      • Prospects
      • Compass Rose
      • Falcons’ Fortunes
  • News
Normal High

Portfolio Category: Prospects

FACIT-65 | HDAX Therapeutics

September 26, 2022 –

Read More from FACIT-65 | HDAX Therapeutics

FACIT-64 | Hyivy Health

September 26, 2022 –

Read More from FACIT-64 | Hyivy Health

FACIT-63 | doctalk

May 19, 2022 –

Read More from FACIT-63 | doctalk

FACIT-62 | OICR

May 16, 2022 –

Read More from FACIT-62 | OICR

FACIT-60 | OICR

May 16, 2022 –

Read More from FACIT-60 | OICR

FACIT-44 | CCRM (Notch Therapeutics)

October 5, 2021 –

Read More from FACIT-44 | CCRM (Notch Therapeutics)

FACIT-45 | OICR

October 5, 2021 –

Read More from FACIT-45 | OICR

FACIT-46 | QurCan Therapeutics

October 5, 2021 –

Read More from FACIT-46 | QurCan Therapeutics

FACIT-48 | Xpan Inc

October 5, 2021 –

Read More from FACIT-48 | Xpan Inc

FACIT-49 | OICR

October 5, 2021 –

Read More from FACIT-49 | OICR

Posts navigation

  • 1
  • 2
  • 3
  • 4
  • »
  • Privacy Policy
  • Accessibility
  • Terms & Conditions
  • Reporting Improper Activities

FACIT
MaRS Centre
661 University Ave., Suite 510
Toronto, Ontario, Canada M5G 0A3

E: info@facit.ca